The American Journal of Managed Care1 天
PAH Treatment Benefits Extend to Patients With Repaired Congenital Heart Disease
Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...
Modifying macrophages in the lung could head off pulmonary hypertension
In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...
Managed Healthcare Executive1 天
PAH Heightens Mortality Risk, Cost for People with Cardiac Diseases
Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.
Grit Daily4 天
Pulmonary Physician Streamlines Critical Care Practices with Zero-Complication Protocol
Implementing the ventilator-associated events (VAE) prevention protocol at Community Health Network has yielded remarkable ...
Pulmonary Arterial Hypertension Clinical Trials and Studies: EMA, PDMA, FDA Approvals ...
The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...
Business Wire8 天
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...
Pulmonary Hypertension News1 天
MTMR7 protein shows promise as PAH treatment in mice
Boosting MTMR7 production reversed signs of pulmonary arterial hypertension in a mouse model of PAH and may serve as a ...